FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)

View source ↗

Summary

The FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

SUPPL AP for AGGRASTAT (TIROFIBAN)